Paul Lehr
General Counsel at LONGEVERON INC.
Net worth: 13 303 $ as of 30/05/2024
Paul Lehr active positions
Companies | Position | Start | End |
---|---|---|---|
LONGEVERON INC. | General Counsel | 31/12/2015 | - |
Corporate Secretary | 31/12/2015 | - | |
Groundupmusic | Director/Board Member | 31/12/2014 | - |
Heart Genomics LLC
Heart Genomics LLC Miscellaneous Commercial ServicesCommercial Services Heart Genomics LLC is a biotechnology company that specializes in developing and commercializing non-invasive, genomic-based clinical diagnostic tests for patients with heart disease or heart failure. Heart Genomics is based in Miami Beach, FL. The private company's diagnostic tests provide personalized and individualized information to each patient and their physician through genomic analysis of the patient's heart tissue or blood sample. This information helps the heart patient and physician make substantially improved and clear treatment decisions. The company was founded by Paul Lehr and Joshua M. Hare, and Paul Lehr has been the CEO since incorporation. | Chief Executive Officer | 31/12/2010 | - |
Founder | 31/12/2010 | - |
Career history of Paul Lehr
Training of Paul Lehr
Brown University | Undergraduate Degree |
University of Florida Levin College of Law | Graduate Degree |
Statistics
International
United States | 6 |
Operational
General Counsel | 1 |
Corporate Secretary | 1 |
Director/Board Member | 1 |
Sectoral
Consumer Services | 3 |
Health Technology | 2 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
LONGEVERON INC. | Health Technology |
Private companies | 2 |
---|---|
Groundupmusic | |
Heart Genomics LLC
Heart Genomics LLC Miscellaneous Commercial ServicesCommercial Services Heart Genomics LLC is a biotechnology company that specializes in developing and commercializing non-invasive, genomic-based clinical diagnostic tests for patients with heart disease or heart failure. Heart Genomics is based in Miami Beach, FL. The private company's diagnostic tests provide personalized and individualized information to each patient and their physician through genomic analysis of the patient's heart tissue or blood sample. This information helps the heart patient and physician make substantially improved and clear treatment decisions. The company was founded by Paul Lehr and Joshua M. Hare, and Paul Lehr has been the CEO since incorporation. | Commercial Services |
- Stock Market
- Insiders
- Paul Lehr
- Experience